Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 4 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Neumora Therapeutics Inc have a median target of 23.50, with a high estimate of 30.00 and a low estimate of 15.00. The median estimate represents a 142.52% increase from the last price of 9.69.
High | 209.6% | 30.00 |
Med | 142.5% | 23.50 |
Low | 54.8% | 15.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 10, 2025.
Average growth rate | +14.85% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼